Tetrahydroaminoacridine in HIV infections. The THA Study Group

Int J Clin Pharmacol Ther Toxicol. 1989 Aug;27(8):408-10.

Abstract

On the basis of a similarity between certain neurological symptoms of AIDS and Alzheimer's disease, the authors studied the effects of tetrahydroaminoacridine (THA) in 9 patients with HIV infection. After 2 months of treatment, the preliminary results showed a significant increase in CD4 lymphocyte count as well as a decrease in p24 antigen level in 8 patients, of whom 4 became negative for the p24 antigen.

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications
  • Acquired Immunodeficiency Syndrome / drug therapy*
  • Adult
  • Alanine Transaminase / blood
  • Aminoacridines / therapeutic use*
  • Aspartate Aminotransferases / blood
  • CD4 Antigens / analysis
  • Female
  • HIV Antigens / analysis
  • Humans
  • Leukocyte Count
  • Male
  • Middle Aged
  • Opportunistic Infections / prevention & control
  • Tacrine / adverse effects
  • Tacrine / therapeutic use*
  • Time Factors

Substances

  • Aminoacridines
  • CD4 Antigens
  • HIV Antigens
  • Tacrine
  • Aspartate Aminotransferases
  • Alanine Transaminase